ICN Pharmaceutical Inc view Eastman Kodak Co's EK> decision sell 2.3 pct share ICN's common stock have effect status drug ribavirin previously report ongoing development drug antiviral field. ICN recently submit data Food Drug Administration study use antiviral drug ribavirin treat AIDS-related disorders. In statement ICN sale effect previously announce plan seek acquisition major pharmaceutical company. ICN plan sale effect long-term research partnership Kodak Kodak's continued funding Nucleic Acid Research Institute. Two ago Kodak agree invest 45 mln dlrs six form operate venture ICN explore biomedical compounds. It acquire 2.3 pct stake ICN result agreement. ICN Kodak confirm ICN continue confidence progress joint project. ICN discussion ICN Kodak regard private sale share ICN decision matter. Reuter 